Silent cardiac comorbidity in arthroplasty patients: an unusual suspect?

Area of Science:

• Cardiology
• Orthopedic Surgery
• Anesthesiology

Background:

• Preoperative cardiac risk assessment is crucial for patients undergoing major elective surgery.
• Routine assessment may not identify all patients with underlying cardiac conditions.
• Hip and knee arthroplasty are common procedures with potential cardiac risks.

Purpose of the Study:

• To evaluate the utility of dobutamine stress echocardiography (DSE) for preoperative cardiac risk assessment in patients undergoing elective hip and knee arthroplasty.
• To determine the prevalence of "silent" cardiac comorbidities in this patient population.
• To assess the correlation between positive DSE results and postoperative cardiac events.

Main Methods:

• A cohort of 109 patients undergoing elective primary hip or knee arthroplasty were subjected to dobutamine stress echocardiography (DSE).
• Patients were stratified based on history of ischemic heart disease.
• DSE results were analyzed for positive findings and correlated with postoperative cardiac events.

Main Results:

• Seven out of 93 patients without a history of ischemic heart disease showed a positive DSE result.
• Five of these seven patients experienced postoperative cardiac events (P = .00).
• This highlights the presence of "silent" cardiac disease in seemingly healthier patients.

Conclusions:

• Dobutamine stress echocardiography (DSE) is effective in identifying significant, previously undiagnosed cardiac comorbidities in patients scheduled for hip and knee arthroplasty.
• Preoperative identification and management of these "silent" cardiac conditions can potentially improve surgical outcomes.
• Routine cardiac risk assessment protocols may need to be enhanced to include stress testing for select patient groups.